Execution against the transformation plan drives margin expansion, adjusted EBITDA growth, and strong free cash flow
Company launches longer-term value improvement initiatives to refocus growth programs, enhance sales teams, reenter the medical market, and implement Total Cost Productivity program globally
Financial and Strategic Highlights
- Net sales of
$124.4 million , down 2.2% versus prior year period; - Operating loss of
$2.7 million and adjusted EBITDA of$14.5 million ; - Free cash flow of
$11.3 million , up significantly versus prior period with positive free cash flow generation of$17 million over the trailing year; - Reduced leverage ratio to 3.37x, down sequentially from 3.87x, supported by improved adjusted EBITDA and cash flow performance;
- Key program wins including attractive awards in EV electric power steering markets;
- Tightened full-year forecast ranges for net sales and adjusted EBITDA while raising free cash flow forecast;
- Successfully supplemented the executive management team with new Chief Operating Officer and Chief Procurement Officer;
- Reentered medical market through creation of NN Medical, the Company’s new medical device division; and
- Launched multiple long-term strategic initiatives to drive enhanced cash flows and shareholder value, focused on growth and cost productivity improvement.
Bevis continued, “We’ve also made considerable progress against many of our commercial goals by leveraging existing customers and markets where we have strong reputations which is helping us win new business. Although we’re encouraged by our new business wins year-to-date and current partnerships, we’re particularly excited about our new market opportunities. Subsequent to quarter-end, we created a division focused on the medical device market, and we are very confident in our ability to leverage our existing footprint and technical market knowhow to immediately win new, profitable business. Along with medical, there are multiple organic entry opportunities such as electric shielding that further strengthen our confidence in our ability to achieve our commercial goals. We look forward to utilizing our unique capabilities and in-depth understanding of market value creation in precision machining and stampings and further applying them to newer markets and customers.”
Third Quarter GAAP Results
Net sales were
Loss from operations was
Income from operations for Power Solutions was
Net loss was
Third Quarter Adjusted Results
Adjusted income from operations for the third quarter of 2023 was
Free cash flow was a generation of cash of
Power Solutions
Net sales for the third quarter of 2023 were
Mobile Solutions
Net sales for the third quarter of 2023 were
2023 Outlook
Based on financial results for thus far year to date, as well as expectations for the remainder of the year, the Company has narrowed its ranged outlook for revenues and Adjusted EBITDA and raised the range of free cash flow expectations for the full year. Full-year 2023 financial outlook is as follows:
- Revenue in the range of
$487 million to$497 million ; - Adjusted EBITDA in the range of
$40 million to$44 million ; and - Free cash flow in the range of
$10 million to$14 million .
Conference Call
NN will discuss its results during its quarterly investor conference call on
NN discloses in this press release the non-GAAP financial measures of adjusted income (loss) from operations, adjusted EBITDA, adjusted net income (loss), adjusted net income (loss) per diluted common share, and free cash flow. Each of these non-GAAP financial measures provides supplementary information about the impacts of restructuring and integration expense, acquisition and transition expenses, foreign exchange impacts on inter-company loans, amortization of intangibles and deferred financing costs, and other non-operating impacts on our business.
The financial tables found later in this press release include a reconciliation of adjusted income (loss) from operations, adjusted operating margin, adjusted EBITDA, adjusted EBITDA margin, adjusted net income (loss), adjusted net income (loss) per diluted share, free cash flow to the
About
Except for specific historical information, many of the matters discussed in this press release may express or imply projections of revenues or expenditures, statements of plans and objectives or future operations or statements of future economic performance. These statements may discuss goals, intentions and expectations as to future trends, plans, events, results of operations or financial condition, or state other information relating to
Investor & Media Contacts:
NNBR@alpha-ir.com
312-445-2870
Financial Tables Follow
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) |
|||||||||||||||
Three Months Ended |
Nine Months Ended |
||||||||||||||
(in thousands, except per share data) | 2023 | 2022 | 2023 | 2022 | |||||||||||
Net sales | $ | 124,443 | $ | 127,297 | $ | 376,737 | $ | 380,726 | |||||||
Cost of sales (exclusive of depreciation and amortization shown separately below) | 104,543 | 108,033 | 320,648 | 316,500 | |||||||||||
Selling, general, and administrative expense | 11,693 | 10,205 | 35,833 | 38,453 | |||||||||||
Depreciation and amortization | 11,577 | 11,193 | 34,643 | 33,962 | |||||||||||
Other operating expense (income), net | (631 | ) | (17 | ) | (526 | ) | 1,862 | ||||||||
Loss from operations | (2,739 | ) | (2,117 | ) | (13,861 | ) | (10,051 | ) | |||||||
Interest expense | 5,739 | 3,746 | 15,484 | 10,673 | |||||||||||
Other expense (income), net | (1,463 | ) | (1,156 | ) | 1,970 | (4,219 | ) | ||||||||
Loss before benefit (provision) for income taxes and share of net income from joint venture | (7,015 | ) | (4,707 | ) | (31,315 | ) | (16,505 | ) | |||||||
Benefit (provision) for income taxes | 245 | 1,068 | (1,381 | ) | (1,514 | ) | |||||||||
Share of net income from joint venture | 1,713 | 1,424 | 3,087 | 3,935 | |||||||||||
Net loss | $ | (5,057 | ) | $ | (2,215 | ) | $ | (29,609 | ) | $ | (14,084 | ) | |||
Other comprehensive loss: | |||||||||||||||
Foreign currency transaction loss | (3,072 | ) | (7,653 | ) | (3,606 | ) | (13,543 | ) | |||||||
Interest rate swap: | |||||||||||||||
Change in fair value, net of tax | — | 904 | (230 | ) | 2,464 | ||||||||||
Reclassification adjustments included in net loss, net of tax | (449 | ) | (116 | ) | (1,366 | ) | (51 | ) | |||||||
Other comprehensive loss | $ | (3,521 | ) | $ | (6,865 | ) | $ | (5,202 | ) | $ | (11,130 | ) | |||
Comprehensive loss | $ | (8,578 | ) | $ | (9,080 | ) | $ | (34,811 | ) | $ | (25,214 | ) | |||
Basic and diluted net loss per share | $ | (0.18 | ) | $ | (0.11 | ) | $ | (0.84 | ) | $ | (0.49 | ) | |||
Shares used to calculate basic and diluted net loss per share | 47,539 | 44,711 | 46,410 | 44,670 |
Condensed Consolidated Balance Sheets (Unaudited) |
|||||||
(in thousands, except per share data) | 2023 |
2022 |
|||||
Assets | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 21,790 | $ | 12,808 | |||
Accounts receivable, net | 73,229 | 74,129 | |||||
Inventories | 70,917 | 80,682 | |||||
Income tax receivable | 12,182 | 12,164 | |||||
Prepaid assets | 3,800 | 2,794 | |||||
Other current assets | 11,339 | 9,123 | |||||
Total current assets | 193,257 | 191,700 | |||||
Property, plant and equipment, net | 185,707 | 197,637 | |||||
Operating lease right-of-use assets | 43,549 | 46,713 | |||||
Intangible assets, net | 62,202 | 72,891 | |||||
Investment in joint venture | 29,131 | 31,802 | |||||
Deferred tax assets | 164 | 102 | |||||
Other non-current assets | 6,688 | 5,282 | |||||
Total assets | $ | 520,698 | $ | 546,127 | |||
Liabilities, Preferred Stock, and Stockholders’ Equity | |||||||
Current liabilities: | |||||||
Accounts payable | $ | 49,347 | $ | 45,871 | |||
Accrued salaries, wages and benefits | 13,243 | 11,671 | |||||
Income tax payable | 340 | 926 | |||||
Short-term debt and current maturities of long-term debt | 6,699 | 3,321 | |||||
Current portion of operating lease liabilities | 5,407 | 5,294 | |||||
Other current liabilities | 13,483 | 11,723 | |||||
Total current liabilities | 88,519 | 78,806 | |||||
Deferred tax liabilities | 4,137 | 5,596 | |||||
Long-term debt, net of current portion | 145,892 | 149,389 | |||||
Operating lease liabilities, net of current portion | 47,841 | 51,411 | |||||
Other non-current liabilities | 16,288 | 9,960 | |||||
Total liabilities | 302,677 | 295,162 | |||||
Commitments and contingencies | |||||||
Series D perpetual preferred stock | 74,295 | 64,701 | |||||
Stockholders' equity: | |||||||
Common stock | 473 | 439 | |||||
Additional paid-in capital | 460,382 | 468,143 | |||||
Accumulated deficit | (274,807 | ) | (245,198 | ) | |||
Accumulated other comprehensive loss | (42,322 | ) | (37,120 | ) | |||
Total stockholders’ equity | 143,726 | 186,264 | |||||
Total liabilities, preferred stock, and stockholders’ equity | $ | 520,698 | $ | 546,127 |
Condensed Consolidated Statements of Cash Flows (Unaudited) |
|||||||
Nine Months Ended |
|||||||
(in thousands) | 2023 | 2022 | |||||
Cash flows from operating activities | |||||||
Net loss | $ | (29,609 | ) | $ | (14,084 | ) | |
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||||
Depreciation and amortization | 34,643 | 33,962 | |||||
Amortization of debt issuance costs and discount | 1,409 | 1,021 | |||||
Paid-in-kind interest | 1,491 | — | |||||
Total derivative loss (gain), net of cash settlements | 3,139 | (4,858 | ) | ||||
Share of net income from joint venture, net of cash dividends received | 851 | 2,310 | |||||
Share-based compensation expense | 2,058 | 3,862 | |||||
Deferred income taxes | (1,531 | ) | (1,831 | ) | |||
Other | (776 | ) | (3,096 | ) | |||
Changes in operating assets and liabilities: | |||||||
Accounts receivable | 335 | (15,667 | ) | ||||
Inventories | 9,692 | (11,314 | ) | ||||
Accounts payable | 5,240 | 9,827 | |||||
Income taxes receivable and payable, net | (576 | ) | (403 | ) | |||
Other | (2,476 | ) | (2,400 | ) | |||
Net cash provided by (used in) operating activities | 23,890 | (2,671 | ) | ||||
Cash flows from investing activities | |||||||
Acquisition of property, plant and equipment | (16,292 | ) | (14,011 | ) | |||
Proceeds from sale of property, plant, and equipment | 2,876 | 460 | |||||
Net cash used in investing activities | (13,416 | ) | (13,551 | ) | |||
Cash flows from financing activities | |||||||
Proceeds from long-term debt | 52,000 | 32,000 | |||||
Repayments of long-term debt | (55,522 | ) | (28,158 | ) | |||
Cash paid for debt issuance costs | (55 | ) | (136 | ) | |||
Proceeds from short-term debt | 3,648 | — | |||||
Other | (1,276 | ) | (2,265 | ) | |||
Net cash provided by (used in) financing activities | (1,205 | ) | 1,441 | ||||
Effect of exchange rate changes on cash flows | (287 | ) | (1,324 | ) | |||
Net change in cash and cash equivalents | 8,982 | (16,105 | ) | ||||
Cash and cash equivalents at beginning of period | 12,808 | 28,656 | |||||
Cash and cash equivalents at end of period | $ | 21,790 | $ | 12,551 |
Reconciliation of GAAP Income (Loss) from Operations to Non-GAAP Adjusted Income (Loss) from Operations | |||||||
(in thousands) | Three Months Ended |
||||||
2023 | 2022 | ||||||
GAAP loss from operations | $ | (2,739 | ) | $ | (2,117 | ) | |
Professional fees | 32 | 341 | |||||
Personnel costs (1) | 903 | 17 | |||||
Facility costs (2) | 1,893 | 644 | |||||
Amortization of intangibles | 3,563 | 3,587 | |||||
Non-GAAP adjusted income from operations (a) | $ | 3,652 | $ | 2,472 | |||
Non-GAAP adjusted operating margin (3) | 2.9 | % | 1.9 | % | |||
GAAP net sales | $ | 124,443 | $ | 127,297 | |||
(in thousands) | Three Months Ended |
||||||
Power Solutions | 2023 | 2022 | |||||
GAAP income from operations | $ | 3,936 | $ | 2,582 | |||
Professional fees | — | 174 | |||||
Personnel costs (1) | 122 | — | |||||
Facility costs (2) | 324 | 300 | |||||
Amortization of intangibles | 2,725 | 2,749 | |||||
Non-GAAP adjusted income from operations (a) | $ | 7,107 | $ | 5,805 | |||
Non-GAAP adjusted operating margin (3) | 15.6 | % | 11.4 | % | |||
GAAP net sales | $ | 45,484 | $ | 51,124 |
(in thousands) | Three Months Ended |
||||||
Mobile Solutions | 2023 | 2022 | |||||
GAAP loss from operations | $ | (1,283 | ) | $ | (474 | ) | |
Personnel costs (1) | 462 | — | |||||
Facility costs (2) | 1,569 | 344 | |||||
Amortization of intangibles | 838 | 838 | |||||
Non-GAAP adjusted income from operations (a) | 1,586 | 708 | |||||
Share of net income from joint venture | 1,713 | 1,424 | |||||
Non-GAAP adjusted income from operations with JV (a) | $ | 3,299 | $ | 2,132 | |||
Non-GAAP adjusted operating margin (3) | 4.2 | % | 2.8 | % | |||
GAAP net sales | $ | 78,961 | $ | 76,122 | |||
(in thousands) | Three Months Ended |
||||||
Elimination | 2023 | 2022 | |||||
GAAP net sales | $ | (2 | ) | $ | 51 |
(1) Personnel costs include recruitment, retention, relocation, and severance costs
(2) Facility costs include costs of opening / closing facilities and relocation / exit of manufacturing operations
(3) Non-GAAP adjusted operating margin = Non-GAAP adjusted income (loss) from operations / GAAP net sales
Reconciliation of GAAP Net Income (Loss) to Non-GAAP Adjusted EBITDA | |||||||
Three Months Ended |
|||||||
(in thousands) | 2023 | 2022 | |||||
GAAP net loss | $ | (5,057 | ) | $ | (2,215 | ) | |
Benefit for income taxes | (245 | ) | (1,068 | ) | |||
Interest expense | 5,739 | 3,746 | |||||
Change in fair value of preferred stock derivatives and warrants | (2,104 | ) | (1,623 | ) | |||
Depreciation and amortization | 11,577 | 11,193 | |||||
Professional fees | 32 | 341 | |||||
Personnel costs (1) | 903 | 17 | |||||
Facility costs (2) | 1,893 | 644 | |||||
Non-cash stock compensation | 1,208 | 307 | |||||
Non-cash foreign exchange (gain) on inter-company loans | 520 | 444 | |||||
Non-GAAP adjusted EBITDA (b) | $ | 14,466 | $ | 11,786 | |||
Non-GAAP adjusted EBITDA margin (4) | 11.6 | % | 9.3 | % | |||
GAAP net sales | $ | 124,443 | $ | 127,297 | |||
(1) Personnel costs include recruitment, retention, relocation, and severance costs | |||||||
(2) Facility costs include costs of opening / closing facilities and relocation / exit of manufacturing operations | |||||||
(3) Non-GAAP adjusted operating margin = Non-GAAP adjusted income (loss) from operations / GAAP net sales | |||||||
(4) Non-GAAP adjusted EBITDA margin = Non-GAAP adjusted EBITDA / GAAP net sales |
Reconciliation of GAAP Net Income (Loss) to Non-GAAP Adjusted Net Income and GAAP Net Income (Loss) per Diluted Common Share to Non-GAAP Adjusted Net Income (Loss) per Diluted Common Share | |||||||
Three Months Ended |
|||||||
(in thousands) | 2023 | 2022 | |||||
GAAP net loss | $ | (5,057 | ) | $ | (2,215 | ) | |
Pre-tax professional fees | 32 | 341 | |||||
Pre-tax personnel costs | 903 | 17 | |||||
Pre-tax facility costs | 1,893 | 644 | |||||
Non-cash foreign exchange (gain) on inter-company loans | 520 | 444 | |||||
Pre-tax change in fair value of preferred stock derivatives and warrants | (2,104 | ) | (1,623 | ) | |||
Pre-tax amortization of intangibles and deferred financing costs | 4,092 | 3,946 | |||||
Tax effect of adjustments reflected above (c) | (162 | ) | (800 | ) | |||
Non-GAAP discrete tax adjustments | — | 749 | |||||
Non-GAAP adjusted net income (loss) (d) | $ | 117 | $ | 1,503 | |||
Three Months Ended |
|||||||
(per diluted common share) | 2023 | 2022 | |||||
GAAP net loss per diluted common share | $ | (0.18 | ) | $ | (0.11 | ) | |
Pre-tax professional fees | — | 0.01 | |||||
Pre-tax personnel costs | 0.02 | — | |||||
Pre-tax facility costs | 0.04 | 0.01 | |||||
Pre-tax foreign exchange (gain) loss on inter-company loans | 0.01 | 0.01 | |||||
Pre-tax change in fair value of preferred stock derivatives and warrants | (0.04 | ) | (0.04 | ) | |||
Pre-tax amortization of intangibles and deferred financing costs | 0.09 | 0.09 | |||||
Tax effect of adjustments reflected above (c) | — | (0.02 | ) | ||||
Non-GAAP discrete tax adjustments | — | 0.02 | |||||
Preferred stock cumulative dividends and deemed dividends | 0.07 | 0.06 | |||||
Non-GAAP adjusted net income (loss) per diluted common share (d) | $ | 0.01 | $ | 0.03 | |||
Shares used to calculate net earnings (loss) per share | 47,539 | 44,711 |
Reconciliation of Operating Cash Flow to Free Cash Flow | |||||||
Three Months Ended |
|||||||
(in thousands) | 2023 | 2022 | |||||
Net cash provided by (used in) operating activities | $ | 15,247 | $ | (127 | ) | ||
Acquisition of property, plant, and equipment | (4,096 | ) | (4,308 | ) | |||
Proceeds from sale of property, plant, and equipment | 99 | 39 | |||||
Free cash flow | $ | 11,250 | $ | (4,396 | ) |
The Company discloses in this presentation the non-GAAP financial measures of adjusted income (loss) from operations, adjusted EBITDA, adjusted net income (loss), adjusted net income (loss) per diluted common share, and free cash flow. Each of these non-GAAP financial measures provides supplementary information about the impacts of acquisition, divestiture and integration related expenses, foreign-exchange impacts on inter-company loans, reorganizational and impairment charges. Over the past five years, we have completed several acquisitions, one of which was transformative for the Company, and sold two of our businesses. The costs we incurred in completing such acquisitions, including the amortization of intangibles and deferred financing costs, and these divestitures have been excluded from these measures because their size and inconsistent frequency are unrelated to our commercial performance during the period, and which we believe are not indicative of our ongoing operating costs. We exclude the impact of currency translation from these measures because foreign exchange rates are not under management’s control and are subject to volatility. Other non-operating charges are excluded as the charges are not indicative of our ongoing operating cost. We believe the presentation of adjusted income (loss) from operations, adjusted EBITDA, adjusted net income (loss), adjusted net income (loss) per diluted common share, and free cash flow provides useful information in assessing our underlying business trends and facilitates comparison of our long-term performance over given periods.
The non-GAAP financial measures provided herein may not provide information that is directly comparable to that provided by other companies in the Company's industry, as other companies may calculate such financial results differently. The Company's non-GAAP financial measures are not measurements of financial performance under GAAP and should not be considered as alternatives to actual income growth derived from income amounts presented in accordance with GAAP. The Company does not consider these non-GAAP financial measures to be a substitute for, or superior to, the information provided by GAAP financial results.
(a) Non-GAAP Adjusted income (loss) from operations represents GAAP income (loss) from operations, adjusted to exclude the effects of restructuring and integration expense; non-operational charges related to acquisition and transition expense, intangible amortization costs for fair value step-up in values related to acquisitions, non-cash impairment charges, and when applicable, our share of income from joint venture operations. We believe this presentation is commonly used by investors and professional research analysts in the valuation, comparison, rating, and investment recommendations of companies in the industrial industry. We use this information for comparative purposes within the industry. Non-GAAP adjusted income (loss) from operations is not a measure of financial performance under GAAP and should not be considered as a measure of liquidity or as an alternative to GAAP income (loss) from operations.
(b) Non-GAAP adjusted EBITDA represents GAAP net income (loss), adjusted to include income taxes, interest expense, write-off of unamortized debt issuance costs, interest rate swap payments and change in fair value that was recognized in earnings, change in fair value of preferred stock derivatives and warrants, depreciation and amortization, charges related to acquisition and transition costs, non-cash stock compensation expense, foreign exchange gain (loss) on inter-company loans, restructuring and integration expense, costs related to divested businesses and litigation settlements, income from discontinued operations, and non-cash impairment charges, to the extent applicable. We believe this presentation is commonly used by investors and professional research analysts in the valuation, comparison, rating, and investment recommendations of companies in the industrial industry. We use this information for comparative purposes within the industry. Non-GAAP adjusted EBITDA is not a measure of financial performance under GAAP and should not be considered as a measure of liquidity or as an alternative to GAAP income (loss) from continuing operations.
(c) This line item reflects the aggregate tax effect of all non-tax adjustments reflected in the respective table.
(d) Non-GAAP adjusted net income (loss) represents GAAP net income (loss) adjusted to exclude the tax-affected effects of charges related to acquisition and transition costs, foreign exchange gain (loss) on inter-company loans, restructuring and integration charges, amortization of intangibles costs for fair value step-up in values related to acquisitions and amortization of deferred financing costs, non-cash impairment charges, write-off of unamortized debt issuance costs, interest rate swap payments and change in fair value, change in fair value of preferred stock derivatives and warrants, costs related to divested businesses and litigation settlements, income (loss) from discontinued operations, and preferred stock cumulative dividends and deemed dividends. We believe this presentation is commonly used by investors and professional research analysts in the valuation, comparison, rating, and investment recommendations of companies in the industrial industry. We use this information for comparative purposes within the industry.
Source: NN, Inc.